| AMH | anti-Müllerian hormone |
| ALD | alcoholic liver disease |
| Akt | protein kinase B |
| ALT | alanine aminotransferase |
| AST | aspartate aminotransferase |
| ATP | adenosine triphosphate |
| BMI | body mass index |
| DM | diabetes mellitus |
| FFA | free fatty acid |
| FAO | fatty acid oxidation |
| FSH | follicle stimulating hormone |
| FoxO1 | forkhead box protein O1 |
| GnRH | gonadotropin-releasing hormone |
| GSK3 | glycogen synthase kinase-3 |
| GWAS | genome-wide association study |
| GLUT4 | glucose trasnsporte-4 |
| GDM | gestational DM |
| HCC | hepatocellular carcinoma |
| HOMA | homeostasis model assessment |
| H&E | hematoxylin and eosin |
| HA | hyperandrogenism |
| HFD | high-fat Diet |
| HFr | high fructose |
| IL | interleukin |
| IR | Insulin resistance |
| IRE1α | inositol-requiring protein 1α |
| ITIH1 | inter-α-trypsin inhibitor heavy chain 1 |
| IGF-1 | insulin-like growth factor 1 |
| JNK | C-Jun N-terminal kinase |
| KD | knockdown |
| MCD | methionine-choline-deficient |
| MAPK | mitogen-activated protein kinase |
| LDs | lipid droplets |
| LXRα | liver X receptor α |
| LH | luteinizing hormone |
| LHCGR | LH/chorionic gonadotropin (CG) receptor |
| mTORC1 | mTOR complex 1 |
| mTORC2 | mTOR complex 2 |
| NAFLD | non-alcoholic fatty liver disease |
| NASH | non-alcoholic steatohepatitis |
| NfκB | nuclear factor kappa B |
| OD | ovulatory dysfunction |
| PCOS | polycystic ovary syndrome |
| PCOM | polycystic ovarian morphology |
| PERK | protein kinase RNA-like ER kinase |
| PNPLA3 | patatin-like phospholipase domain-containing protein 3 |
| PI3K | phosphatidylinositol-3-kinase |
| ROS | reactive oxygen species |
| RIDD | regulated IRE1-dependent decay |
| RACK2 | receptor for activated C-kinase 2 |
| SHBG | sex hormone-binding globulin |
| TG | triacylglycerol |
| TNF | tumor necrosis factor |
| T2D | type 2 diabetes |
| UPR | unfolded protein response |
| ULK1 | unc-51-like kinase 1 |
| VDAC | voltage-dependent anion channel |
| VLDL | very low-density lipoprotein |
| WHO | World Health Organization |
| XBP1 | X-box binding protein 1 |
| XO | xanthine oxidase |
| ER | endoplasmic reticulum |
| HDL | high-density lipoproteins |
| RLT | reverse lipid transport |
| DAMP | danger-activated molecular patterns |
| PAMP | pathogen-activated molecular patterns |
| KC | Kupffer cell |
| TLR | toll-like receptors |
| NLR | nucleotide-binding oligomerization domain (NOD)-like receptors |
| FADD | FAS-associated death domain proteins |
| CARD | Caspase recruitment domain |
| IRAK | IL-1 receptor-associated kinase 1 |
| ASC | apoptosis-associated speck-like protein containing a CARD |
| HR | hazard ratio |
| CI | confidence interval |
| LC-MS | liquid chromatography-mass spectrometry |
| THR | thyroid receptor hormone |
| GLP-1 | glucagon-like peptide-1 |
| HVPG | hepatic venous pressure gradient |
| FGF | fibroblast growth factor |